JP2016512519A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512519A5 JP2016512519A5 JP2016501176A JP2016501176A JP2016512519A5 JP 2016512519 A5 JP2016512519 A5 JP 2016512519A5 JP 2016501176 A JP2016501176 A JP 2016501176A JP 2016501176 A JP2016501176 A JP 2016501176A JP 2016512519 A5 JP2016512519 A5 JP 2016512519A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- seq
- cytotoxic protein
- cytotoxic
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019117230A JP6896021B2 (ja) | 2013-03-12 | 2019-06-25 | 特定の細胞型の選択的死滅のための細胞標的化結合領域と志賀毒素ａサブユニット領域とを含む細胞毒性タンパク質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361777130P | 2013-03-12 | 2013-03-12 | |
| US61/777,130 | 2013-03-12 | ||
| PCT/US2014/023231 WO2014164693A2 (en) | 2013-03-12 | 2014-03-11 | Cytotoxic proteins comprising cell-targeting binding regions and shiga toxin a subunit regions for selective killing of specific cell types |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019117230A Division JP6896021B2 (ja) | 2013-03-12 | 2019-06-25 | 特定の細胞型の選択的死滅のための細胞標的化結合領域と志賀毒素ａサブユニット領域とを含む細胞毒性タンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016512519A JP2016512519A (ja) | 2016-04-28 |
| JP2016512519A5 true JP2016512519A5 (https=) | 2017-04-13 |
| JP6548630B2 JP6548630B2 (ja) | 2019-07-24 |
Family
ID=50625074
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016501176A Expired - Fee Related JP6548630B2 (ja) | 2013-03-12 | 2014-03-11 | 特定の細胞型の選択的死滅のための細胞標的化結合領域と志賀毒素ａサブユニット領域とを含む細胞毒性タンパク質 |
| JP2016501171A Expired - Fee Related JP6472784B2 (ja) | 2013-03-12 | 2014-03-11 | 細胞内在化を誘導するためのｃｄ２０結合免疫毒素及びそれを用いる方法 |
| JP2019009370A Expired - Fee Related JP6745923B2 (ja) | 2013-03-12 | 2019-01-23 | 細胞内在化を誘導するためのｃｄ２０結合免疫毒素及びそれを用いる方法 |
| JP2019117230A Expired - Fee Related JP6896021B2 (ja) | 2013-03-12 | 2019-06-25 | 特定の細胞型の選択的死滅のための細胞標的化結合領域と志賀毒素ａサブユニット領域とを含む細胞毒性タンパク質 |
| JP2020132606A Pending JP2020193205A (ja) | 2013-03-12 | 2020-08-04 | 細胞内在化を誘導するためのｃｄ２０結合免疫毒素及びそれを用いる方法 |
| JP2021095748A Pending JP2021164456A (ja) | 2013-03-12 | 2021-06-08 | 特定の細胞型の選択的死滅のための細胞標的化結合領域と志賀毒素ａサブユニット領域とを含む細胞毒性タンパク質 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016501171A Expired - Fee Related JP6472784B2 (ja) | 2013-03-12 | 2014-03-11 | 細胞内在化を誘導するためのｃｄ２０結合免疫毒素及びそれを用いる方法 |
| JP2019009370A Expired - Fee Related JP6745923B2 (ja) | 2013-03-12 | 2019-01-23 | 細胞内在化を誘導するためのｃｄ２０結合免疫毒素及びそれを用いる方法 |
| JP2019117230A Expired - Fee Related JP6896021B2 (ja) | 2013-03-12 | 2019-06-25 | 特定の細胞型の選択的死滅のための細胞標的化結合領域と志賀毒素ａサブユニット領域とを含む細胞毒性タンパク質 |
| JP2020132606A Pending JP2020193205A (ja) | 2013-03-12 | 2020-08-04 | 細胞内在化を誘導するためのｃｄ２０結合免疫毒素及びそれを用いる方法 |
| JP2021095748A Pending JP2021164456A (ja) | 2013-03-12 | 2021-06-08 | 特定の細胞型の選択的死滅のための細胞標的化結合領域と志賀毒素ａサブユニット領域とを含む細胞毒性タンパク質 |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US20160068577A1 (https=) |
| EP (4) | EP2970478B1 (https=) |
| JP (6) | JP6548630B2 (https=) |
| KR (2) | KR102110127B1 (https=) |
| CN (2) | CN111363047A (https=) |
| AU (1) | AU2014249107C1 (https=) |
| CA (2) | CA2902324A1 (https=) |
| CY (1) | CY1123138T1 (https=) |
| DK (1) | DK2970487T3 (https=) |
| ES (2) | ES2800630T3 (https=) |
| HR (1) | HRP20200553T1 (https=) |
| HU (1) | HUE049470T2 (https=) |
| IL (3) | IL240433B (https=) |
| LT (1) | LT2970487T (https=) |
| MX (1) | MX378807B (https=) |
| PL (1) | PL2970487T3 (https=) |
| PT (1) | PT2970487T (https=) |
| RS (1) | RS60280B1 (https=) |
| SI (1) | SI2970487T1 (https=) |
| SM (1) | SMT202000266T1 (https=) |
| WO (2) | WO2014164680A1 (https=) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2010012473A (es) | 2008-05-23 | 2011-02-23 | Siwa Corp | Metodos, composiciones y aparato para facilitar la regeneracion. |
| RS60280B1 (sr) * | 2013-03-12 | 2020-06-30 | Molecular Templates Inc | Citotoksični proteini koji sadrže ciljane vezujuće regione za ćelije i regioni shiga toksina a podjedinice za selektivno ubijanje određenih vrsta ćelija |
| CN111909278B (zh) | 2014-01-27 | 2024-04-09 | 分子模板公司 | Mhc i类表位递送多肽 |
| WO2017019623A2 (en) | 2015-07-26 | 2017-02-02 | Molecular Templates, Inc. | Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes |
| US20210138076A2 (en) * | 2014-01-27 | 2021-05-13 | Molecular Templates, Inc. | Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes |
| US10421958B2 (en) | 2014-02-05 | 2019-09-24 | Molecular Templates, Inc. | Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity |
| US11142584B2 (en) | 2014-03-11 | 2021-10-12 | Molecular Templates, Inc. | CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same |
| AU2015229583B2 (en) | 2014-03-11 | 2020-07-09 | Molecular Templates, Inc. | Proteins comprising amino-terminal proximal Shiga toxin A Subunit effector regions and cell-targeting immunoglobulin-type binding regions |
| ES2723774T3 (es) * | 2014-03-11 | 2019-09-02 | Molecular Templates Inc | Proteínas que comprenden regiones de unión, regiones efectoras de la subunidad A de toxina Shiga y motivos señal de localización de retículo endoplasmático carboxi terminal |
| US20150328263A1 (en) | 2014-05-14 | 2015-11-19 | University Of Maryland, Baltimore | Cardiac stem cells for cardiac repair |
| ES2919749T3 (es) | 2014-06-11 | 2022-07-28 | Molecular Templates Inc | Moléculas dirigidas a células citotóxicas resistentes a la escisión por proteasa |
| CN107001459B (zh) | 2014-09-19 | 2021-11-23 | Siwa有限公司 | 用于治疗炎症和自身免疫紊乱的抗age抗体 |
| US10387178B2 (en) * | 2014-10-29 | 2019-08-20 | Red Hat Israel, Ltd. | Idle based latency reduction for coalesced interrupts |
| JP6882978B2 (ja) | 2014-10-29 | 2021-06-02 | バイスクルアールディー・リミテッド | Ｍｔ１−ｍｍｐに特異的な二環性ペプチドリガンド |
| US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
| US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
| MX2017010072A (es) | 2015-02-05 | 2017-11-09 | Molecular Templates Inc | Moleculas multivalentes que se enlazan a cd20, las cuales comprenden regiones efectoras de la subunidad a de la toxina shiga, y composiciones enriquecidas de las mismas. |
| AU2016271124C1 (en) | 2015-05-30 | 2020-05-14 | Molecular Templates, Inc. | De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same |
| PT3337829T (pt) | 2016-02-19 | 2020-02-10 | Siwa Corp | Método e composição para o tratamento do cancro, matando células cancerosas metastáticas e prevenindo as metástases do cancro usando anticorpos para produtos finais de glicação avançada (pga) |
| US11248057B2 (en) | 2016-03-07 | 2022-02-15 | Vib Vzw | CD20 binding single domain antibodies |
| CA3057829A1 (en) | 2016-04-15 | 2017-10-19 | Siwa Corporation | Anti-age antibodies for treating neurodegenerative disorders |
| AU2017340387A1 (en) * | 2016-10-04 | 2019-05-02 | University Of Florida Research Foundation, Inc. | Targeted effector proteins and uses thereof |
| CA3040802A1 (en) | 2016-10-24 | 2018-05-03 | Orionis Biosciences Nv | Targeted mutant interferon-gamma and uses thereof |
| AU2017355218B2 (en) * | 2016-11-02 | 2024-02-22 | Universität Basel | Immunologically discernible cell surface variants for use in cell therapy |
| WO2018106895A1 (en) | 2016-12-07 | 2018-06-14 | Molecular Templates, Inc. | Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation |
| US10610104B2 (en) | 2016-12-07 | 2020-04-07 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
| EP3573648B1 (en) | 2017-01-25 | 2023-11-22 | Molecular Templates, Inc. | Cell-targeting molecules comprising de-immunized, shiga toxin a subunit effectors and cd8+ t-cell epitopes |
| EP3580230B1 (en) | 2017-02-07 | 2026-04-22 | Vib Vzw | Immune-cell targeted bispecific chimeric proteins and uses thereof |
| US20210138213A1 (en) | 2017-03-30 | 2021-05-13 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
| CA3059803A1 (en) | 2017-04-13 | 2018-10-18 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody |
| JP7301757B2 (ja) | 2017-06-26 | 2023-07-03 | バイスクルアールディー・リミテッド | 検出可能部分を持つ二環式ペプチドリガンドおよびその使用 |
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| CN111183147B (zh) | 2017-08-04 | 2024-07-05 | 拜斯科技术开发有限公司 | Cd137特异性的双环肽配体 |
| CA3076099A1 (en) * | 2017-09-22 | 2019-03-28 | Kite Pharma, Inc. | Linkers for chimeric antigen receptors |
| TWI825046B (zh) | 2017-12-19 | 2023-12-11 | 英商拜西可泰克斯有限公司 | Epha2特用之雙環胜肽配位基 |
| GB201721265D0 (en) | 2017-12-19 | 2018-01-31 | Bicyclerd Ltd | Bicyclic peptide ligands specific for EphA2 |
| US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
| JP2021514953A (ja) | 2018-02-23 | 2021-06-17 | バイスクルテクス・リミテッド | 多量体二環式ペプチドリガンド |
| AU2019257343A1 (en) | 2018-04-17 | 2020-09-10 | Molecular Templates, Inc. | HER2-targeting molecules comprising de-immunized, Shiga toxin A Subunit scaffolds |
| US12227565B2 (en) | 2018-06-20 | 2025-02-18 | Biora Therapeutics, Inc. | Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine |
| WO2019246312A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunomodulator |
| IL279489B2 (en) | 2018-06-22 | 2025-10-01 | Bicycletx Ltd | Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate |
| GB201810316D0 (en) | 2018-06-22 | 2018-08-08 | Bicyclerd Ltd | Peptide ligands for binding to EphA2 |
| WO2020081493A1 (en) | 2018-10-16 | 2020-04-23 | Molecular Templates, Inc. | Pd-l1 binding proteins |
| WO2020084305A1 (en) * | 2018-10-23 | 2020-04-30 | Bicycletx Limited | Bicyclic peptide ligands and uses thereof |
| US20220249814A1 (en) | 2018-11-19 | 2022-08-11 | Progenity, Inc. | Methods and devices for treating a disease with biotherapeutics |
| GB201820325D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for psma |
| GB201820295D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for MT1-MMP |
| GB201820288D0 (en) | 2018-12-13 | 2019-01-30 | Bicycle Tx Ltd | Bicycle peptide ligaands specific for MT1-MMP |
| US12551567B2 (en) | 2018-12-21 | 2026-02-17 | Bicyclerd Limited | Bicyclic peptide ligands specific for PD-L1 |
| JP2022514618A (ja) | 2018-12-21 | 2022-02-14 | バイスクルテクス・リミテッド | Ｐｄ－ｌ１に特異的な二環式ペプチドリガンド |
| GB201900529D0 (en) | 2019-01-15 | 2019-03-06 | Bicycletx Ltd | Bicyclic peptide ligands specific for CD38 |
| CN113454108B (zh) | 2019-01-23 | 2025-02-14 | 米伦纽姆医药公司 | 包含去免疫化志贺菌毒素a亚基效应子的cd38结合蛋白 |
| WO2020154475A1 (en) | 2019-01-23 | 2020-07-30 | Molecular Templates, Inc. | Proteins comprising modified immunoglobulin variable light chains |
| AR119677A1 (es) | 2019-01-23 | 2022-01-05 | Millennium Pharm Inc | Dominios de unión anti-cd38 |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| JP7150999B2 (ja) | 2019-02-18 | 2022-10-11 | エーティービー セラピューティクス | 植物細胞または植物全体においてバインダー‐毒素融合タンパク質を産生する方法 |
| JP7689079B2 (ja) | 2019-03-28 | 2025-06-05 | オリオニス バイオサイエンシズ，インコーポレイテッド | 治療用インターフェロンアルファ１タンパク質 |
| TWI860386B (zh) | 2019-07-30 | 2024-11-01 | 英商拜西可泰克斯有限公司 | 異質雙環肽複合物 |
| CN114423793A (zh) | 2019-09-18 | 2022-04-29 | 分子模板公司 | 包含志贺菌毒素a亚基支架的pd-l1结合分子 |
| WO2021055816A1 (en) | 2019-09-18 | 2021-03-25 | Molecular Templates, Inc. | Pd-l1 binding molecules comprising shiga toxin a subunit scaffolds |
| WO2021102445A1 (en) | 2019-11-24 | 2021-05-27 | Molecular Templates, Inc. | Uses of cd20-binding molecules and additional therapeutic agents |
| CN121197633A (zh) | 2019-12-13 | 2025-12-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| IL300248A (en) | 2020-08-03 | 2023-03-01 | Bicycletx Ltd | peptide-based linkers |
| JP2023536627A (ja) | 2020-08-05 | 2023-08-28 | ドラゴンフライ セラピューティクス， インコーポレイテッド | Ｅｇｆｒを標的とする抗体およびその使用 |
| EP4262858A1 (en) | 2020-12-16 | 2023-10-25 | Molecular Templates, Inc. | Clinical methods for use of a pd-l1-binding molecule comprising a shiga toxin effector |
| WO2022197945A1 (en) | 2021-03-17 | 2022-09-22 | Molecular Templates, Inc. | Pd-l1 binding proteins comprising shiga toxin a subunit scaffolds and cd8+ t cell antigens |
| JP7707820B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707831B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707827B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707825B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707828B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707821B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707830B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707833B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707822B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707834B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707835B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707824B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707836B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707829B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707826B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| JP7707832B2 (ja) * | 2021-10-06 | 2025-07-15 | 株式会社三洋物産 | 遊技機 |
| WO2023107954A1 (en) | 2021-12-08 | 2023-06-15 | Dragonfly Therapeutics, Inc. | Antibodies targeting 5t4 and uses thereof |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5668255A (en) | 1984-06-07 | 1997-09-16 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
| US6022950A (en) | 1984-06-07 | 2000-02-08 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
| WO1991009871A1 (en) | 1989-12-22 | 1991-07-11 | Seragen Incorporated | Hybrid molecules having translocation region and cell-binding region |
| WO1994026910A1 (en) | 1993-05-12 | 1994-11-24 | Xoma Corporation | Immunotoxins comprising gelonin and an antibody |
| US5621083A (en) | 1991-11-04 | 1997-04-15 | Xoma Corporation | Immunotoxins comprising ribosome-inactivating proteins |
| US6146850A (en) | 1991-11-04 | 2000-11-14 | Xoma Corporation | Proteins encoding gelonin sequences |
| CZ295838B6 (cs) | 1996-09-09 | 2005-11-16 | Zealand Pharma A/S | Způsob výroby peptidů |
| WO1998011229A2 (en) | 1996-09-10 | 1998-03-19 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| US6306393B1 (en) | 1997-03-24 | 2001-10-23 | Immunomedics, Inc. | Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| CA2222993A1 (en) | 1998-02-04 | 1999-08-04 | The Ontario Cancer Institute | A method for using a ribosome-inactivating protein complex as a structural template and a molecular search engine in the design, construction and screening of combinatorial protein libraries |
| ES2205849T3 (es) | 1998-07-22 | 2004-05-01 | Osprey Pharmaceuticals Limited | Conjugados para tratar alteraciones inflamatorias y asociadas con daños tisulares. |
| US7157418B1 (en) | 1998-07-22 | 2007-01-02 | Osprey Pharmaceuticals, Ltd. | Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| US7527787B2 (en) | 2005-10-19 | 2009-05-05 | Ibc Pharmaceuticals, Inc. | Multivalent immunoglobulin-based bioactive assemblies |
| US20010031485A1 (en) | 2000-03-22 | 2001-10-18 | Sibtech, Inc. | Recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor fragments |
| US7267973B2 (en) | 2000-03-22 | 2007-09-11 | Sibtech, Inc. | Nucleic acids encoding recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor |
| CN101289511A (zh) | 2000-04-11 | 2008-10-22 | 杰南技术公司 | 多价抗体及其应用 |
| CA2763913C (en) | 2001-08-10 | 2014-10-28 | Aberdeen University | Antigen binding domains |
| WO2003066854A1 (fr) * | 2002-02-04 | 2003-08-14 | Yoshida, Hideo | Agent anticancereux utilisant des variantes de verotoxines |
| EP3263596A1 (en) | 2002-12-16 | 2018-01-03 | Genentech, Inc. | Immunoglobulin variants and uses thereof |
| US7875586B2 (en) * | 2002-12-20 | 2011-01-25 | The Johns Hopkins University | Treatment of metastatic colon cancer with b-subunit of shiga toxin |
| US8147832B2 (en) | 2003-08-14 | 2012-04-03 | Merck Patent Gmbh | CD20-binding polypeptide compositions and methods |
| US20070298434A1 (en) | 2004-03-26 | 2007-12-27 | Jean Gariepy | Library of Toxin Mutants, and Methods of Using Same |
| WO2006040153A2 (en) | 2004-10-13 | 2006-04-20 | Ablynx N.V. | Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease |
| EP2567976B1 (en) | 2005-03-23 | 2017-07-19 | Genmab A/S | Antibodies against CD38 for treatment of multiple myeloma |
| MX2007015476A (es) * | 2005-06-14 | 2008-02-25 | Amgen Inc | Formulaciones de proteina autoamortiguadoras. |
| JP2009502936A (ja) | 2005-07-25 | 2009-01-29 | トルビオン ファーマシューティカルズ， インコーポレイテッド | Ｃｄ２０特異的結合分子の単一投与量 |
| ES2493465T3 (es) | 2005-09-26 | 2014-09-11 | Molecular Templates, Inc. | Biblioteca a partir de toxinas mutantes y procesos de utilización de la misma |
| GB0524788D0 (en) | 2005-12-05 | 2006-01-11 | Affibody Ab | Polypeptides |
| BRPI0720647A2 (pt) | 2006-12-29 | 2014-01-14 | Osprey Pharmaceuticals Usa Inc | Processos de seleção e produção de toxinas modificadas, conjugados contendo toxinas modificadas e usos dos mesmos |
| FR2915398B1 (fr) * | 2007-04-25 | 2012-12-28 | Lab Francais Du Fractionnement | "ensemble de moyens pour le traitement d'une pathologie maligne, d'une maladie auto-immune ou d'une maladie infectieuse" |
| PL2197903T3 (pl) | 2007-09-04 | 2015-03-31 | Us Gov Health & Human Services | Delecje w domenie ii egzotoksyny a psuedomonas zmniejszające toksyczność niespecyficzną |
| CA2705289A1 (en) * | 2007-11-13 | 2009-05-22 | The Scripps Research Institute | Production of cytotoxic antibody-toxin fusion in eukaryotic algae |
| EP2220120A2 (en) | 2007-11-27 | 2010-08-25 | Ablynx N.V. | Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same |
| JP6049163B2 (ja) * | 2008-07-21 | 2016-12-21 | イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． | 改善された治療上の特徴のための抗体の構造変異体 |
| KR101832499B1 (ko) | 2009-01-23 | 2018-02-26 | 더 헨리 엠. 잭슨 파운데이션 포 더 어드벤스먼트 오브 밀리터리 메디신, 인코포레이티드 | 시가 독소 2형 단백질 기반 방법 및 조성물 |
| US20120258104A1 (en) | 2009-07-22 | 2012-10-11 | Cenix Bioscience Gmbh | Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes |
| GB201013989D0 (en) | 2010-08-20 | 2010-10-06 | Univ Southampton | Biological materials and methods of using the same |
| PL219845B1 (pl) | 2011-01-05 | 2015-07-31 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Przeciwnowotworowe białko fuzyjne |
| CA2825023A1 (en) * | 2011-01-26 | 2012-08-02 | Cenix Bioscience Gmbh | Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes |
| WO2012104344A1 (en) | 2011-02-01 | 2012-08-09 | Genmab A/S | Human antibodies and antibody-drug conjugates against cd74 |
| US8895006B2 (en) | 2011-03-04 | 2014-11-25 | Rutgers, The State University Of New Jersey | Ricin ribosome binding protein compositions and methods of use thereof |
| RU2600067C2 (ru) | 2011-05-06 | 2016-10-20 | Дзе Гавермент Оф Дзе Юнайтед Стейтс Оф Америка Эз Репрезентед Бай Дзе Секретари Оф Дзе Депармент Оф Хелс Энд Хьюман Сёрвисез | Рекомбинантный иммунотоксин, нацеленный на мезотелин |
| PL397167A1 (pl) | 2011-11-28 | 2013-06-10 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Przeciwnowotworowe bialko fuzyjne |
| DE102012024450A1 (de) * | 2012-12-13 | 2014-06-18 | Maschinenfabrik Niehoff Gmbh & Co. Kg | Wickelspule für ein Gebinde, sowie Verfahren zu dessen Herstellung und Abwicklung |
| RS60280B1 (sr) | 2013-03-12 | 2020-06-30 | Molecular Templates Inc | Citotoksični proteini koji sadrže ciljane vezujuće regione za ćelije i regioni shiga toksina a podjedinice za selektivno ubijanje određenih vrsta ćelija |
| GB2519786A (en) | 2013-10-30 | 2015-05-06 | Sergej Michailovic Kiprijanov | Multivalent antigen-binding protein molecules |
| CN111909278B (zh) | 2014-01-27 | 2024-04-09 | 分子模板公司 | Mhc i类表位递送多肽 |
| US10421958B2 (en) | 2014-02-05 | 2019-09-24 | Molecular Templates, Inc. | Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity |
| US11142584B2 (en) | 2014-03-11 | 2021-10-12 | Molecular Templates, Inc. | CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same |
| ES2723774T3 (es) | 2014-03-11 | 2019-09-02 | Molecular Templates Inc | Proteínas que comprenden regiones de unión, regiones efectoras de la subunidad A de toxina Shiga y motivos señal de localización de retículo endoplasmático carboxi terminal |
| AU2015229583B2 (en) | 2014-03-11 | 2020-07-09 | Molecular Templates, Inc. | Proteins comprising amino-terminal proximal Shiga toxin A Subunit effector regions and cell-targeting immunoglobulin-type binding regions |
| AU2016271124C1 (en) * | 2015-05-30 | 2020-05-14 | Molecular Templates, Inc. | De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same |
-
2014
- 2014-03-11 RS RS20200451A patent/RS60280B1/sr unknown
- 2014-03-11 HR HRP20200553TT patent/HRP20200553T1/hr unknown
- 2014-03-11 US US14/774,130 patent/US20160068577A1/en not_active Abandoned
- 2014-03-11 US US14/774,609 patent/US10450354B2/en active Active
- 2014-03-11 ES ES14726015T patent/ES2800630T3/es active Active
- 2014-03-11 EP EP14720298.0A patent/EP2970478B1/en active Active
- 2014-03-11 DK DK14726015.2T patent/DK2970487T3/da active
- 2014-03-11 PL PL14726015T patent/PL2970487T3/pl unknown
- 2014-03-11 PT PT147260152T patent/PT2970487T/pt unknown
- 2014-03-11 HU HUE14726015A patent/HUE049470T2/hu unknown
- 2014-03-11 MX MX2015012808A patent/MX378807B/es unknown
- 2014-03-11 CA CA2902324A patent/CA2902324A1/en active Pending
- 2014-03-11 CN CN202010215621.7A patent/CN111363047A/zh active Pending
- 2014-03-11 WO PCT/US2014/023198 patent/WO2014164680A1/en not_active Ceased
- 2014-03-11 LT LTEP14726015.2T patent/LT2970487T/lt unknown
- 2014-03-11 WO PCT/US2014/023231 patent/WO2014164693A2/en not_active Ceased
- 2014-03-11 EP EP20154062.2A patent/EP3666795A1/en not_active Withdrawn
- 2014-03-11 EP EP20155659.4A patent/EP3683240A1/en not_active Withdrawn
- 2014-03-11 KR KR1020197016790A patent/KR102110127B1/ko not_active Expired - Fee Related
- 2014-03-11 CN CN201480013350.XA patent/CN105051067B/zh not_active Expired - Fee Related
- 2014-03-11 AU AU2014249107A patent/AU2014249107C1/en not_active Ceased
- 2014-03-11 SM SM20200266T patent/SMT202000266T1/it unknown
- 2014-03-11 EP EP14726015.2A patent/EP2970487B1/en active Active
- 2014-03-11 JP JP2016501176A patent/JP6548630B2/ja not_active Expired - Fee Related
- 2014-03-11 ES ES14720298T patent/ES2808726T3/es active Active
- 2014-03-11 SI SI201431553T patent/SI2970487T1/sl unknown
- 2014-03-11 CA CA2902432A patent/CA2902432A1/en not_active Abandoned
- 2014-03-11 JP JP2016501171A patent/JP6472784B2/ja not_active Expired - Fee Related
- 2014-03-11 KR KR1020157023206A patent/KR101990341B1/ko not_active Expired - Fee Related
-
2015
- 2015-08-09 IL IL240433A patent/IL240433B/en active IP Right Grant
-
2018
- 2018-02-20 US US15/899,428 patent/US20180258144A1/en not_active Abandoned
-
2019
- 2019-01-23 JP JP2019009370A patent/JP6745923B2/ja not_active Expired - Fee Related
- 2019-06-25 JP JP2019117230A patent/JP6896021B2/ja not_active Expired - Fee Related
- 2019-09-12 US US16/568,638 patent/US20200002387A1/en not_active Abandoned
- 2019-11-18 IL IL270745A patent/IL270745B/en active IP Right Grant
-
2020
- 2020-05-19 CY CY20201100456T patent/CY1123138T1/el unknown
- 2020-08-04 JP JP2020132606A patent/JP2020193205A/ja active Pending
-
2021
- 2021-06-08 JP JP2021095748A patent/JP2021164456A/ja active Pending
- 2021-06-14 IL IL283969A patent/IL283969B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016512519A5 (https=) | ||
| HRP20200553T1 (hr) | Citotoksični proteini koji sadrže vezne regije koje ciljaju na stanice i regije podjedinice a shiga toksina za selektivno ubijanje specifičnih tipova stanica | |
| JP2020103296A5 (https=) | ||
| JP2020079267A5 (https=) | ||
| JP7346294B2 (ja) | 対合が改善されたｔ細胞受容体ｔ細胞 | |
| JP2020511935A5 (https=) | ||
| HRP20200640T1 (hr) | De-imunizirane, okosnice podjedinice shiga toksina a i molekule koje ciljaju stanice koje ih sadrže | |
| US20190381160A1 (en) | Personalized delivery vector-based immunotherapy and uses thereof | |
| TW201639594A (zh) | 利用重組李斯特菌菌株之組合療法 | |
| PH12020550600A1 (en) | Novel engineered t cell receptors and immune therapy using the same | |
| JP2018535668A5 (https=) | ||
| PE20240645A1 (es) | Peptido inmunogenico derivado de moleculas de antigenos leucocitarios humanos (hla) como biomarcador en la inmunoterapia de diversos tumores | |
| JP2016156828A5 (https=) | ||
| JP2018076329A (ja) | Ｃｄ４＋ｔ細胞応答を向上するための修飾されたエピトープ | |
| CN108884468A (zh) | 基于个性化递送载体的免疫疗法及其用途 | |
| EP4357356A3 (en) | Antigenic peptides for prevention and treatment of b-cell malignancy | |
| RU2556128C2 (ru) | Профилактическая противораковая вакцина | |
| Alpizar et al. | Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies | |
| Dasgupta et al. | Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma | |
| UA124331C2 (uk) | Пептид, здатний зв'язуватися з молекулою головного комплексу гістосумісності (mhc) людини i класу | |
| CN113754756B (zh) | 一种识别hla-a*02:01/e629-38的tcr及其应用 | |
| Kaštánková et al. | Combined cancer immunotherapy against aurora kinase A | |
| Gritzapis et al. | Pooled peptides from HER-2/neu-overexpressing primary ovarian tumours induce CTL with potent antitumour responses in vitro and in vivo | |
| US10849967B2 (en) | Nucleic acid molecules encoding for chimeric CSPG4 proteins and therapeutic uses thereof | |
| Kim | CD8-dependent tumor growth inhibition by tumor cells genetically modified with 4-1BBL |